COMPARISON OF REGIONAL BLOOD-BRAIN TRANSPORT KINETICS BETWEEN GLUCOSE AND FLUORODEOXYGLUCOSE

被引:0
|
作者
LEAR, JL [1 ]
ACKERMAN, RF [1 ]
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT RADIOL SCI,DIV NUCL MED & BIOPHYS,LOS ANGELES,CA 90024
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The fluorodeoxyglucose (FDG) method for estimating regional cerebral glucose metabolic rate (LCMRglc) requires that a fixed relationship (the "lumped constant") exists between net FDG and glucose (GLC) extraction throughout the brain. In addition to the relative rate of metabolism between FDG and GLC, this assumed constant is affected by the relative rate of blood-to-brain FDG transport compared to that of glucose. However, little data is available regarding the regional stability of the FDG versus GLC transport-rate relationship. We therefore used high resolution, quantitative dual-tracer digital autoradiography to directly compare the blood-to-brain transport rate constants (Kl) of radiolabeled GLC and FDG in normal and pharmacologically-stimulated rats. The rats were given 45 sec terminal intravenous infusions of a mixture of F-18-FDG and 14 C-GLC. Autoradiograms of the brain representing the FDG and GLC tracer concentrations were produced, digitized, and converted into digital images of Kl. We found that the global Kl values of FDG and GLC were not significantly different from each other. However, detailed analysis revealed that some structures in the normal animals, such as the hippocampus and cerebellum, had different quantitative patterns of FDG transport compared to GLC transport. Thus, our results indicate that the relationship between GLC and FDG transport is not uniform throughout the brain as has previously been assumed. This observation suggests that regional variations in the type and distribution of glucose transporters may exist and that the fluorodeoxyglucose "lumped constant" may vary somewhat among different brain regions.
引用
下载
收藏
页码:1819 / 1824
页数:6
相关论文
共 50 条
  • [41] Blood-brain barrier glucose transport: Effects of hyper- and hypoglycemia revisited.
    Simpson, IA
    Appel, NM
    Hokari, M
    Oki, J
    Holman, GD
    Maher, F
    Koehler-Stec, EM
    Vannucci, SJ
    Smith, QR
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S68 - S68
  • [42] Molecular architecture of the brain microvasculaturePerspective on blood-brain transport
    Lester R. Drewes
    Journal of Molecular Neuroscience, 2001, 16 : 93 - 98
  • [43] GLUCOSE-TRANSPORT ACROSS BLOOD-BRAIN BARRIER, AS RELATED TO AGE AND MECLOFENOXATE TREATMENT
    OERIU, S
    WINTER, D
    DOBRE, V
    BRUHIS, S
    JOURNAL DE PHARMACOLOGIE, 1973, 4 (04) : 497 - 503
  • [44] STARVATION ACCELERATES BLOOD-BRAIN GLUCOSE TRANSFER
    CHRISTENSEN, TG
    DIEMER, NH
    LAURSEN, H
    GJEDDE, A
    ACTA PHYSIOLOGICA SCANDINAVICA, 1981, 112 (02): : 221 - 223
  • [45] BLOOD-BRAIN GLUCOSE TRANSFER IN SPREADING DEPRESSION
    GJEDDE, A
    HANSEN, AJ
    QUISTORFF, B
    JOURNAL OF NEUROCHEMISTRY, 1981, 37 (04) : 807 - 812
  • [47] Blood-brain barrier transport kinetics of NOTA-modified proteins: the somatropin case
    Bracke, Nathalie
    Janssens, Yorick
    Wynendaele, Evelien
    Tack, Liesa
    Maes, Alex
    Van De Wiele, Christophe
    Sathekge, Mike
    De Spiegeleer, Bart
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (01): : 105 - 114
  • [48] Blood-brain barrier transport kinetics of the neuromedin peptides NMU, NMN, NMB and NT
    Gevaert, Bert
    Wynendaele, Evelien
    Stalmans, Sofie
    Bracke, Nathalie
    D'Hondt, Matthias
    Smolders, Ilse
    van Eeckhaut, Ann
    De Spiegeleer, Bart
    NEUROPHARMACOLOGY, 2016, 107 : 460 - 470
  • [49] BLOOD-BRAIN TRANSFER OF GLUCOSE AND GLUCOSE ANALOGS IN NEWBORN RATS
    FUGLSANG, A
    LOMHOLT, M
    GJEDDE, A
    JOURNAL OF NEUROCHEMISTRY, 1986, 46 (05) : 1417 - 1428
  • [50] Prediction of drug transport through the blood-brain barrier in vivo:: A comparison between two in vitro cell models
    Lundquist, S
    Renftel, M
    Brillault, J
    Fenart, L
    Cecchelli, R
    Dehouck, MP
    PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 976 - 981